WINDTREE THERAPEUTICS INC /DE/ Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Windtree Therapeutics Inc /De/ quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Windtree Therapeutics Inc /De/ Entity Common Stock, Shares Outstanding for the quarter ending August 19, 2024 was 592K shares, a 88.5% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 592K -4.56M -88.5% Aug 19, 2024 10-Q 2024-08-19
Q1 2024 9.18M +8.27M +910% Apr 1, 2024 10-K 2024-04-16
Q3 2023 5.15M -33.5M -86.7% Nov 9, 2023 10-Q 2023-11-09
Q2 2023 5.15M -25.5M -83.2% Aug 7, 2023 10-Q 2023-08-07
Q1 2023 909K -27.6M -96.8% Mar 30, 2023 10-K 2023-03-31
Q3 2022 38.6M +10.3M +36.6% Nov 14, 2022 10-Q 2022-11-14
Q2 2022 30.6M +3.92M +14.7% Aug 11, 2022 10-Q 2022-08-11
Q1 2022 28.5M +2.21M +8.43% Mar 30, 2022 10-K 2022-03-31
Q3 2021 28.3M Nov 10, 2021 10-Q 2021-11-10
Q2 2021 26.7M +9.82M +58.1% Aug 5, 2021 10-Q 2021-08-05
Q1 2021 26.3M -14.8M -36.1% Mar 29, 2021 10-K 2021-03-29
Q4 2020 16.9M Nov 16, 2020 10-Q 2020-11-16
Q2 2020 16.9M -15.3M -47.5% Aug 13, 2020 10-Q 2020-08-14
Q1 2020 41.1M +8.96M +27.9% Apr 1, 2020 10-K 2020-04-03
Q3 2019 32.2M +28.4M +754% Nov 11, 2019 10-Q 2019-11-14
Q2 2019 32.2M +28.4M +754% Aug 9, 2019 10-Q 2019-08-14
Q1 2019 32.1M +28.4M +753% Apr 5, 2019 10-K/A 2019-04-23
Q3 2018 3.77M -59.4M -94% Nov 2, 2018 10-Q 2018-11-14
Q2 2018 3.77M Aug 3, 2018 10-Q 2018-08-14
Q1 2018 3.77M -5.67M -60.1% Apr 6, 2018 10-K 2018-04-17
Q3 2017 63.2M +54.7M +646% Nov 8, 2017 10-Q 2017-11-14
Q1 2017 9.44M +1.25M +15.2% Mar 23, 2017 10-K 2017-03-31
Q3 2016 8.48M -104M -92.4% Nov 7, 2016 10-Q 2016-11-14
Q2 2016 8.31M -103M -92.5% Aug 5, 2016 10-Q 2016-08-10
Q1 2016 8.19M -77.4M -90.4% Mar 15, 2016 10-K/A 2016-03-29
Q3 2015 112M +26.7M +31.3% Nov 2, 2015 10-Q 2015-11-05
Q2 2015 111M +25.8M +30.3% Aug 1, 2015 10-Q 2015-08-10
Q1 2015 85.6M +890K +1.05% Mar 6, 2015 10-K 2015-03-16
Q3 2014 85.3M +4.59M +5.68% Oct 31, 2014 10-Q 2014-11-07
Q2 2014 85.2M +52.6M +161% Jul 31, 2014 10-Q 2014-08-07
Q1 2014 84.7M +40.9M +93.5% Mar 7, 2014 10-K 2014-03-17
Q3 2013 80.7M +37.2M +85.6% Nov 8, 2013 10-Q 2013-11-12
Q2 2013 32.6M -10.8M -24.9% Aug 2, 2013 10-Q 2013-08-08
Q1 2013 43.8M +457K +1.06% Apr 30, 2013 10-Q 2013-05-07
Q3 2012 43.5M +19M +77.6% Nov 2, 2012 10-Q 2012-11-14
Q2 2012 43.4M +19.2M +79.2% Jul 31, 2012 10-Q 2012-08-14
Q1 2012 43.3M Mar 21, 2012 10-K 2012-03-30
Q3 2011 24.5M Nov 8, 2011 10-Q 2011-11-14
Q2 2011 24.2M Aug 5, 2011 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.